Alzheimer's disease amyloid-β pathology in the lens of the eye. (August 2022)

• Record Type: Journal Article
• Authors: Moncaster, Juliet A.; Moir, Robert D.; Burton, Mark A.; Chadwick, Oliver; Minaeva, Olga; Alvarez, Victor E.; Ericsson, Maria; Clark, John I.; McKee, Ann C.; Tanzi, Rudolph E.; Goldstein, Lee E.
• Is Part Of: Experimental eye research. Volume 221(2022)
• Publication Date: 2022-08
• Subjects: Aβ -- Alzheimer's disease -- Amyloid-β -- Amyloid precursor protein -- Biomarker -- Cataract -- Down syndrome -- Lens -- Protein aggregation -- Quasi-elastic light scattering -- Transgenic mouse model; Aβ amyloid-β -- AD Alzheimer's disease -- AH aqueous humor -- APP amyloid precursor protein -- DS Down syndrome (trisomy 21) -- FAD familial Alzheimer's disease -- GWAS genome-wide association study -- MCI mild cognitive impairment -- QLS quasi-elastic light scattering -- SNC supranuclear cataract -- Tg2576 Swedish mutation (APP-Swe) transgenic mouse model of Alzheimer's disease; Ophthalmology -- Periodicals; Eye -- Periodicals; Œil -- Périodiques; Ophthalmology; Periodicals; Electronic journals; 612.8405
• DOI: 10.1016/j.exer.2022.108974
• Languages: English
• ISSNs: 0014-4835

Abstract

Abstract: Neuropathological hallmarks of Alzheimer's disease (AD) include pathogenic accumulation of amyloid-β (Aβ) peptides and age-dependent formation of amyloid plaques in the brain. AD-associated Aβ neuropathology begins decades before onset of cognitive symptoms and slowly progresses over the course of the disease. We previously reported discovery of Aβ deposition, β-amyloidopathy, and co-localizing supranuclear cataracts (SNC) in lenses from people with AD, but not other neurodegenerative disorders or normal aging. We confirmed AD-associated Aβ molecular pathology in the lens by immunohistopathology, amyloid histochemistry, immunoblot analysis, epitope mapping, immunogold electron microscopy, quantitative immunoassays, and tryptic digest mass spectrometry peptide sequencing. Ultrastructural analysis revealed that AD-associated Aβ deposits in AD lenses localize as electron-dense microaggregates in the cytoplasm of supranuclear (deep cortex) fiber cells. These Aβ microaggregates also contain αB-crystallin and scatter light, thus linking Aβ pathology and SNC phenotype expression in the lenses of people with AD. Subsequent research identified Aβ lens pathology as the molecular origin of the distinctive cataracts associated with Down syndrome (DS, trisomy 21), a chromosomal disorder invariantly associated with early-onset Aβ accumulation and Aβ amyloidopathy in the brain. Investigation of 1249 participants in the Framingham Eye Study found that AD-associated quantitative traits in brain and lens are co-heritable. Moreover, AD-associated lens traits preceded MRI brain traits and cognitive deficits by a decade or more and predicted future AD. A genome-wide association study of bivariate outcomes in the same subjects identified a new AD risk factor locus in the CTNND2 gene encoding δ-catenin, a protein that modulates Aβ production in brain and lens. Here we report identification of AD-related human Aβ (hAβ) lens pathology and age-dependent SNC phenotype expression in the Tg2576 transgenic mouse model of AD. Tg2576 mice express Swedish mutant human amyloid precursor protein (APP-Swe), accumulate hAβ peptides and amyloid pathology in the brain, and exhibit cognitive deficits that slowly progress with increasing age. We found that Tg2576 trangenic (Tg + ) mice, but not non-transgenic (Tg – ) control mice, also express human APP, accumulate hAβ peptides, and develop hAβ molecular and ultrastructural pathologies in the lens. Tg2576 Tg + mice exhibit age-dependent Aβ supranuclear lens opacification that recapitulates lens pathology and SNC phenotype expression in human AD. In addition, we detected hAβ in conditioned medium from lens explant cultures prepared from Tg + mice, but not Tg – control mice, a finding consistent with constitutive hAβ generation in the lens. In vitro studies showed that hAβ promoted mouse lens protein aggregation detected by quasi-elastic light scattering (QLS) spectroscopy. These results support mechanistic (genotype-phenotype) linkage between Aβ pathology and AD-related phenotypes in lens and brain. Collectively, our findings identify Aβ pathology as the shared molecular etiology of two age-dependent AD-related cataracts associated with two human diseases (AD, DS) and homologous murine cataracts in the Tg2576 transgenic mouse model of AD. These results represent the first evidence of AD-related Aβ pathology outside the brain and point to lens Aβ as an optically-accessible AD biomarker for early detection and longitudinal monitoring of this devastating neurodegenerative disease. Highlights: We review Aβ lens pathology in Alzheimer's disease (AD) and Down syndrome (DS). Light-scattering Aβ microaggregates lead to AD-related supranuclear cataract (SNC). We report human Aβ lens pathology and SNC phenotype in the Tg2576 transgenic mouse model of AD. Collectively, our results provide the first evidence of AD-related Aβ pathology outside the brain. Lens Aβ can be noninvasively measured in vivo for early AD detection and monitoring.